tm logo
VERTEX CELL AND GENETIC THERAPIES
Live/Pending
NOTICE OF ALLOWANCE - ISSUED

issued

on 24 Sep 2024

Last Applicant/ Owned by

50 Northern Avenue

Boston

MA

02210

Serial Number

98195949 filed on 25th Sep 2023

Registration Number

N/A

Correspondent Address

Lisa Tittemore

Lisa Tittemore SUNSTEIN LLP

BOSTON, MA 02110

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

VERTEX CELL AND GENETIC THERAPIES

medical and scientific research; medical and scientific research in the field of gene therapy; medical and scientific research in the field of nucleic acid; medical and scientific research in the field of gene editing for developing cells and pharmaceuticals for medical and clinical use; research and development of pharmaceuticals using gene editing

Classification Information


Class [042]
Computer & Software Services & Scientific Services


medical and scientific research; medical and scientific research in the field of gene therapy; medical and scientific research in the field of nucleic acid; medical and scientific research in the field of gene editing for developing cells and pharmaceuticals for medical and clinical use; research and development of pharmaceuticals using gene editing


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 98195949

Mark Type

No Service Mark

Attorney Docket Number

No 1618/2186

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
24th Sep 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
30th Jul 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
30th Jul 2024PUBLISHED FOR OPPOSITION
10th Jul 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
21st Jun 2024APPROVED FOR PUB - PRINCIPAL REGISTER
20th Jun 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
20th Jun 2024TEAS/EMAIL CORRESPONDENCE ENTERED
20th Jun 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
05th Apr 2024NON-FINAL ACTION E-MAILED
05th Apr 2024NON-FINAL ACTION WRITTEN